A total of 54 patients will enter this two treatment parallel-design study. The probability is 90 percent that the study will detect a treatment difference at a two sided with p-value ≤ 0.01, if the true difference between the treatments in aneuploidy rate is 25 %. This is based on the assumption that the standard deviation of the response variable is 0.180.